KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 76 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $17,643,000 | -39.9% | 1,151,622 | 0.0% | 1.02% | -51.5% |
Q2 2020 | $29,343,000 | +149.7% | 1,151,622 | +51.7% | 2.10% | +97.7% |
Q1 2020 | $11,750,000 | +2.9% | 759,050 | -10.0% | 1.06% | -0.6% |
Q2 2019 | $11,421,000 | -25.0% | 843,478 | 0.0% | 1.07% | -29.6% |
Q1 2019 | $15,233,000 | +104.7% | 843,478 | +218.4% | 1.52% | +59.9% |
Q4 2018 | $7,440,000 | +10.2% | 264,878 | 0.0% | 0.95% | +39.5% |
Q3 2018 | $6,754,000 | +109.2% | 264,878 | +42.4% | 0.68% | +63.7% |
Q2 2018 | $3,228,000 | – | 186,073 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |